Table 2.
Annually newly diagnosed cases according to the Paris classification age.
| Paris classification age, n (%) | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| IBD | ||||
| 0–9 | 12 (35.3) | 4 (11.8) | 10 (29.4) | 8 (23.5) |
| 10–16 | 31 (18.8) | 35 (21.2) | 37 (22.4) | 62 (37.6) |
| 17–18 | 20 (19.1) | 18 (17.1) | 35 (33.3) | 32 (30.5) |
| CD | ||||
| 0–9 | 8 (32.0) | 3 (12.0) | 9 (36.0) | 5 (20.0) |
| 10–16 | 22 (17.2) | 28 (21.9) | 30 (23.4) | 48 (37.5) |
| 17–18 | 9 (14.0) | 13 (20.3) | 20 (31.3) | 22 (34.4) |
| UC | ||||
| 0–9 | 4 (44.4) | 1 (11.1) | 1 (11.1) | 3 (33.3) |
| 10–16 | 9 (24.4) | 7 (18.9) | 7 (18.9) | 14 (37.8) |
| 17–18 | 11(26.8) | 5 (12.2) | 15 (36.6) | 10 (24.4) |
IBD, inflammatory bowel disease; CD, Crohn's disease; UC, ulcerative colitis.